Association between sensitivity to thyroid hormone indices and frailty in the elderly: a cross-sectional study

老年人甲状腺激素敏感性指标与虚弱症之间的关联:一项横断面研究

阅读:2

Abstract

OBJECTIVE: Frailty is a prevalent geriatric syndrome that affects several systems and lacks accurate evaluation indications. Previous studies on the association between thyroid function and frailty have contradicted. This study introduced the thyroid hormone sensitivity indices to analyze their connection with frailty and evaluate its usefulness in assessing frailty. METHODS: A total of 1030 Chinese elderly individuals were included. The FRAIL scale was utilized to assess the frailty status of subjects. The thyroid hormone sensitivity indices, including the following: Thyrotrophic Thyroxine Resistance Index (TT4RI), Thyroid Stimulating Hormone Index (TSHI), Thyroid Feedback Quantile-based Index (TFQI) and Free Triiodothyronine/Free Thyroxine (FT3/FT4), were calculated based on thyroid function. A multivariate logistic regression analysis assessed the association between frailty and these markers. RESULTS: The study findings indicated that frailty groups exhibited lower levels of FT3 and TSH compared to non-frailty groups. Additionally, the central sensitivity index of thyroid hormone [TFQI(FT3)] and the peripheral sensitivity index (FT3/FT4) were also lower in frailty groups. Following the adjustment for multiple variables, FT3 (OR=0.640, 95%CI: 0.534-0.768, p <0.001), TSHI (OR=0.829, 95%CI: 0.708-0.971, p =0.020), TFQI(FT3) (OR=0.358, 95%CI: 0.233-0.550, p <0.001) and FT3/FT4 (OR=0.006, 95%CI: 0.001-0.058, p <0.001) showed a negative connection with the score of FRAIL scale. CONCLUSION: Serum FT3 and TSH declined in frail patients, whereas there was no alteration in serum FT4. Both the decrease of central sensitivity index of thyroid hormone, TSHI and TFQI(FT3), and peripheral sensitivity index, FT3/FT4, were associated with frailty assessed by FRAIL scale. Specific thyroid measures, especially FT3, TFQI(FT3) and FT3/FT4, would be served as easily measurable indications that are essential for evaluating frailty.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。